Sunovo Capital

Sunovo Capital

Sunovo Capital operates as a China-focused private equity and venture capital firm, investing across seed, start-up, and growth stages. The firm deploys capital primarily into technology and healthcare companies, leveraging its Hangzhou base within the Yangtze River Delta innovation corridor. Its investment approach favors concentrated positions where the firm can support portfolio companies with operational guidance and strategic introductions, particularly for businesses navigating China's domestic regulatory landscape. The firm's strategy spans enterprise software, artificial intelligence, industrial technology, healthcare services, and consumer sectors. Sunovo participates in both early-stage venture rounds and growth equity investments, targeting companies that have achieved initial product-market fit and require capital to scale within China or across Asia. The firm structures direct equity investments and has, in select cases, facilitated cross-border structuring for portfolio companies seeking secondary listings or international partnership channels. Headquartered in Hangzhou, Sunovo Capital maintains a lean investment team that evaluates hundreds of opportunities annually, typically closing a handful of new commitments each year. The firm's deal flow benefits from Hangzhou's concentration of Alibaba alumni entrepreneurs and Zhejiang province's deep private-sector manufacturing and technology base. Information on total assets under management, fund structures, and limited partner composition remains closed to public disclosure. Sunovo's structural distinction lies in its positioning as an independent Hangzhou-based investor outside the orbit of the dominant Beijing-Shanghai-Shenzhen venture complexes. This geographic anchor gives the firm preferential access to Zhejiang's entrepreneur network while maintaining the capacity to syndicate with larger domestic and international co-investors on competitive rounds.